natgillin/translations-raw huggingface dataset:
Xydalba may have a minor influence on the ability to drive and use machines, as dizziness has been reported in a small number of patients (see section 4.8).
Zdravilo Xydalba ima lahko blag vpliv na sposobnost vožnje in upravljanja s stroji, pri majhnem številu pacientov so namreč zabeležili omotico (glejte poglavje 4.8).
Xydalba must be reconstituted with sterile water for injections and subsequently diluted with 50 mg/ml (5 %) glucose solution for infusion.
Zdravilo Xydalba mora biti rekonstituirano s sterilno vodo za injekcije in nato razredčeno s 50 mg/ml (5 %) raztopine glukoze za infundiranje.
Xydalba must be reconstituted with sterile water for injections and subsequently diluted with 50 mg/ml (5 %) glucose solution for infusion.
Zdravilo Xydalba mora biti rekonstituirano s sterilno vodo za injekcije in potem razredčeno s 50 mg/ml (5 %) raztopine glukoze za infundiranje.
Xydalba must not be mixed with other medicinal products or intravenous solutions.
Zdravila Xydalba ne smete mešati z drugimi zdravili ali raztopinami za infundiranje.
Xydalba should be administered with caution in patients known to be hypersensitive to other glycopeptides since cross-hypersensitivity may occur.
Posebej pozorno se mora zdravilo Xydalba uporabljati pri pacientih, za katere je znano, da so preobčutljivi na druge glikopeptide, saj se lahko pojavi navzkrižna preobčutljivost.
Xydalba vials are for single-use only.
Viale zdravila Xydalba so namenjene za enkratno uporabo.
Xydalba’s safety profile is comparable to that of other antibiotics of the glycopeptide class; side effects affecting hearing and kidney function, which are typical for glycopeptides, have not been shown with the proposed regimens of Xydalba in the clinical trials.
Varnostni profil zdravila Xydalba je primerljiv z varnostnim profilom drugih glikopeptidnih antibiotikov, pri čemer v kliničnih preskušanjih ob zdravljenju z zdravilom Xydalba po predlaganih režimih niso opazili neželenih učinkov na sluh in delovanje ledvic, ki so sicer značilni za glikopeptide.
xylohexopyra- nosyl]oxy]-1- oxa-6- azacyclopent- de-can-15-one expressed as tulathromycin equivalents
xylohexopyran osyl]oxy]-1- oxa-6- azacyclopenta decan-15-on, izraženi kot ekvivalent tulatromicina
Xyrem 500 mg/mL (applies to carton only)
Xyrem 500 mg/ml (samo za škatlo)
Xyrem 6 – 9
Xyrem 6–9
Xyrem is supplied in a 240 mL amber plastic bottle containing 180 mL of oral solution and closed with a child-resistant cap.
Zdravilo Xyrem je na voljo v 240-mililitrski plastenki jantarne barve, ki vsebuje 180 ml peroralne raztopine in je zaprta z zaporko, varno za otroke.
Xyrem will affect you if you drive or operate tools or machines.
Zdravilo Xyrem bo vplivalo na vas pri vožnji ali upravljanju z orodji ali stroji.
Xyrem with food, drink and alcohol
Zdravilo Xyrem skupaj s hrano, pijačo in alkoholom
y cutaneous),
kožni),
Y The Marketing Authorisation Holder must implement nationally an educational plan, prior to marketing, and as agreed with the competent authorities in the Member States.
Y Imetnik dovoljenja za promet z zdravilom mora pred trženjem na nacionalni ravni uvesti izobraževalni načrt, kot je dogovorjeno s pristojnimi organi v državah članicah.
Y181C, K101E, G190A/S, K103N, V106A/M, V108I, Y188C/L, A98G, F227L and M230L.
Y181C, K101E, G190A/S, K103N, V106A/M, V108I, Y188C/L, A98G, F227L and M230L
Y181C, K101E, G190A/S, K103N, V106A/M, V108I, Y188C/L, A98G, F227L and M230L.
Y181C, K101E, G190A/S, K103N, V106A/M, V108I, Y188C/L, A98G, F227L in M230L
Y365X
G361R
Y56H alone could not be evaluated due to poor replication capacity, however, the combination of Y56H and D168A/V/Y reduced the activity of paritaprevir by 700- to 4118- fold.
Y56H same ni bilo mogoče oceniti zaradi slabe replikacijske sposobnosti, a kombinacija Y56H in D168A/V/Y je zmanjšala aktivnost paritaprevirja za 700- do 4118-krat.
Y: body weight of the patient in kg
Y: telesna masa bolnika v kilogramih
Y: body weight of the patient in kg D: dose of busulfan (see section 4.2)
D: odmerek busulfana (glejte poglavje 4.2)
Yarvitan 5 mg/ml oral solution for dogs
Yarvitan 5 mg/ml peroralna raztopina za pse
Yarvitan 5 mg/ml oral solution for dogs Mitratapide
Yarvitan 5 mg/ml peroralna raztopina za pse Mitratapid
Yawning
trebuhu
Yawning
Zehanje
Yawning
zehanje,
Year 1
leto 1
Year 1 (%)
1. leto (%)
Year 1 and 3 frequencies of malignancies are shown in Table 3, except for cases of PTLD which are presented at 1 year and > 3 years (median days of follow-up were 1,199 days for belatacept MI, 1,206 days for belatacept LI, and 1,139 days for ciclosporin).
Pogostnost novotvorb po 1-letnem in 3-letnem zdravljenju je prikazana v tabeli 3, razen za primere PTLB, ki so prikazani po 1-letnem in več kot 3-letnem zdravljenju (mediano število dni spremljanja je pri BI režimu zdravljenja z belataceptom 1.199 dni, pri MI režimu uporabe belatacepta 1.206 dni in pri ciklosporinu 1.139 dni).
Year 1 and Year 3 frequencies of infections occurring by treatment group are shown in Table 4.
Pogostnost okužb po 1-letnem ali 3-letnem zdravljenju je po skupinah zdravljenja prikazana v tabeli 4.
Year 3 (%)
3. leto (%)
Year 3a
3. letoa
Year 4
Leto 4
Year 4 a
4. letoa
Year 4a
4. letoa
Year 5
leto 5
Year 5 a
5. letoa
Year 5a
5. letoa
Year 6
Leto 6
Year 7
Leto 7
Year 8
Leto 8
Yearly submission
Letno sporočanje podatkov
years
2 leti
years
2 leti.
years
3 leta
years
4 leta
years
5 let
years
5 let.
years
leti
Years living with study partner
Večletno skupno življenje s partnerjem v študiji
years of age weighing less than
Otroci od 6. leta starosti in mladostniki od starosti, ki tehtajo manj kot 40 kg
years.
2 leti.
years.
3 leta
years.
3 leta.
years.
4 leta
years.
4 leta.
years.
5 let
years.
5 let.
years.
Dve leti.
years.
leta
years.
leta.
years.
leti
years.
leti.
Yeast infection of the skin (tinea versicolor)
okužba kože s kvasovkami (tinea versicolor)
Yeast powder
Kvas v prahu
Yellow and almond shaped tablets, marked "C 20" on one side.
Tablete rumene barve in mandljeve oblike, z oznako "C 20" na eni strani.
Yellow and double-arrow shaped tablets, debossed with “5 MG” on one side and “4760” on the other.
Rumene tablete v obliki dvojne puščice, z vtisnjenim “5 MG” na eni strani in “4760” na drugi strani.
Yellow body and a blue cap of 24 x 8 mm imprinted with “IPX066” and “195” in blue ink.
Velikosti 24 × 8 mm z rumenim telesom in modrim pokrovčkom, z vtisnjenima oznakama »IPX066« in »195« z modrim črnilom.
Yellow caplet shaped tablets of approximately 20 mm in length, marked with “T375” on one side.
Rumene, ovalne tablete, dolge približno 20 mm z oznako ‘T375’ na eni strani.
Yellow caplet-shaped tablets of approximately 20 mm in length, marked with ‘T375’ on one side.
Rumene ovalne tablete, dolge približno 20 mm z oznako ‘T375’ na eni strani.
Yellow coloured circular flat bevelled edge orodispersible tablets with ‘2’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako '2' na eni strani.
Yellow coloured circular flat bevelled edge orodispersible tablets with ‘3’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako '3' na eni strani.
Yellow coloured circular flat bevelled edge orodispersible tablets with ‘OL’ debossed on one side and ‘5’ debossed on other side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '5' na drugi strani.
Yellow coloured circular flat bevelled edge orodispersible tablets with ‘OL’ debossed on one side and ‘6’ debossed on other side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '6' na drugi strani.
Yellow coloured circular flat bevelled edge tablets with ‘1’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako '1' na eni strani.
Yellow coloured circular flat bevelled edge tablets with ‘2’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako '2' na eni strani.
Yellow coloured circular flat bevelled edge tablets with ‘3’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako '3' na eni strani.
Yellow coloured circular flat bevelled edge tablets with ‘OL’ debossed on one side and ‘4’ debossed on other side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '4' na drugi strani.
Yellow coloured circular flat bevelled edge tablets with ‘OL’ debossed on one side and ‘5’ debossed on other side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '5' na drugi strani.
Yellow coloured circular flat bevelled edge tablets with ‘OL’debossed on one side and ‘4’ debossed on one side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '4' na drugi strani.
Yellow coloured circular flat bevelled edge with ‘OL’ debossed on one side and ‘6’ debossed on other side.
Rumene, okrogle, ploščate tablete z zaobljenim robom, z oznako 'OL' na eni strani in oznako '6' na drugi strani.
Yellow coloured, oval, biconvex, debossed ‘L 65’ and break line on one side and plain on the other side.
Rumene, podolgovate, bikonveksne tablete, z vtisnjeno oznako ‘L 65’ in zarezo na eni strani ter brez oznak na drugi strani.
Yellow coloured, oval, biconvex, film coated tablet, debossed ‘L 65’ and break line on one side and plain on the other side.
Rumene, podolgovate, bikonveksne, filmsko obložene tablete z vtisnjeno oznako ‘L 65’ in zarezo na eni strani ter brez oznak na drugi strani.
Yellow debossed with [Abbott logo] and “KA”.
Rumena, z vtisnjenima oznakama [Abbottov logo] in "KA".
Yellow discolouration of eyes and skin (jaundice)
rumeno obarvanje beločnic ali kože (zlatenica)
Yellow ferric oxide (E172)
Rumeni železov oksid (E172)
Yellow fever vaccine: risk of fatal generalised vaccinale disease (see section 4.3).
Cepivo proti rumeni mrzlici: tveganje za smrtno generalizirano bolezen po cepljenju (glejte poglavje 4.3).
Yellow fever vaccine: Risk of fatal generalised vaccinial disease (see section 4.3).
Cepivo proti rumeni mrzlici: Tveganje za smrtno generalizirano vakcinijo (glejte poglavje 4.3).
Yellow fever vaccine: risk of fatal generalized vaccine-induced disease.
Cepivo proti rumeni mrzlici: tveganje generalizirane, s cepivom sprožene bolezni s smrtnim izidom.
Yellow film-coated tablets marked "gsk" on one side and "1/500" on the other.
Rumene filmsko obložene tablete z oznako "gsk" na eni strani in "1/500" na drugi strani.
Yellow film-coated tablets marked "gsk" on one side and "2/1000" on the other.
Rumene filmsko obložene tablete z oznako "gsk" na eni strani in "2/1000" na drugi strani.
Yellow iron oxide (E 172) Red iron oxide (E 172) Titanium dioxide (E 171)
makrogol sojin lecitin rumeni železov oksid (E172) rdeči železov oksid (E172) titanov dioksid (E171)
Yellow iron oxide (E172)
mukec rumeni železov oksid (E172)
Yellow iron oxide (E172) Red iron oxide (E172) Black iron oxide (E172) Titanium dioxide (E171)
želatina rumeni železov oksid (E172) rdeči železov oksid (E172) črni železov oksid (E172) titanov dioksid (E171)
Yellow iron oxide (E172) Red iron oxide (E172) Titanium dioxide (E171)
želatina rumeni železov oksid (E172) rdeči železov oksid (E172) titanov dioksid (E171)
Yellow iron oxide (E172) Titanium dioxide (E171) Gelatin
Ovojnica kapsule: rumeni železov oksid (E172) titanov dioksid (E171) želatina
Yellow iron oxide dehydrate (E172) Red iron oxide dehydrate (E172) Talc (E553b)
Rumeni železov oksid dihidrat (E172) Rdeči železov oksid dihidrat (E172) Smukec (E553b)
Yellow iron oxide Ethylcellulose Titanium dioxide
rumeni železov oksid etilceluloza
Yellow placebo tablets missed
Pozabili ste vzeti placebo tablete
Yellow Plunger Visible After Injection
Rumeni bat, viden po injiciranju
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘10’ on the other side.
Rumene, okrogle, ravne tablete s krožnim krožnim robom in vtisnjenim napisom "APO" na eni strani in "OL" nad "10" na drugi strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘15’ on the other side.
Rumene, okrogle, ravne tablete s krožnim krožnim robom in vtisnjenim napisom "APO" na eni strani in "OL" nad "15" na drugi strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘20’ on the other side.
Rumene, okrogle, ravne tablete s krožnim krožnim robom in vtisnjenim napisom "APO" na eni strani in "OL" nad "20" na drugi strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘5’ on the other side.
Rumene, okrogle, ravne tablete s krožnim krožnim robom in vtisnjenim napisom "APO" na eni strani in "OL" nad "5" na drugi strani.
yellow shaft
rumenega valja
Yellow skin
rumeno obarvanje kože;
Yellow skin (jaundice)
porumenelost kože (zlatenica),
yellow skin (jaundice)
rumena koža (zlatenica),
yellow skin (jaundice) abdominal pain
porumenelost kože (zlatenico), bolečine v trebuhu.
yellow skin (jaundice) abdominal pain
porumenelost kože (zlatenico), trebušno bolečino.
yellow skin (jaundice) abdominal pain.
porumenelost kože (zlatenico), trebušno bolečino.
Yellow skin (jaundice) caused by abnormal liver function.
Rumeno obarvanje kože (zlatenica), ki jo povzroči nenormalno delovanje jeter.
yellow skin (jaundice) caused by liver problems
rumeno obarvanje kože (zlatenica) zaradi težav z jetri;
yellow skin (jaundice) severe and life-threatening skin rashes (Stevens-Johnson syndrome/ toxic epidermal necrolysis)
rumena koža (zlatenica), hudi in življenjsko nevarni kožni izpuščaji (Stevens Johnsonov sindrom/toksična epidermalna nekroliza),
yellow skin (jaundice),
porumenelost kože (zlatenica),
yellow skin (jaundice), abdominal pain
rumena koža (zlatenica), trebušna bolečina,
yellow skin (jaundice), abdominal pain
rumena koža (zlatenica), trebušne bolečina,
yellow skin and eyes, nausea, loss of appetite, dark-coloured urine (signs of liver disorders)
rumena koža in oči, slabost, izguba apetita, temno obarvan urin (znaki jetrnih bolezni)
Yellow skin or eyes, itching or pain in the abdomen (tummy) caused by inflammation of the liver
rumena obarvanost kože ali oči, srbečica, bolečine v trebuhu zaradi vnetja jeter
yellow skin or eyes, itching, or pain in the abdomen (stomach) caused by inflammation of the liver
porumenelost kože ali oči, srbenje ali bolečina v trebuhu (želodcu) zaradi vnetja jeter
yellow skin or eyes, itching, or pain in the abdomen (stomach) caused by inflammation of the liver damage to kidney tubules
porumenelost kože ali oči, srbenje ali bolečina v trebuhu (želodcu), ki jo povzroča vnetje jeter; poškodbe ledvičnih tubulov.
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver
rumena obarvanost kože ali oči, srbečica, bolečine v trebuhu zaradi vnetja jeter
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver (hepatitis)
rumena obarvanost kože ali oči, srbečica, bolečine v trebuhu zaradi vnetja jeter (hepatitis)
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver,
rumena obarvanost kože ali oči, srbečica, bolečine v trebuhu zaradi vnetja jeter,
Yellow skin/skin discoloration, excess pigmentation of the skin, hair colour change, rash on the palms of the hands and soles of the feet, rash, dryness of the skin.
porumenela koža/obarvanje kože, čezmerna pigmentacija kože, sprememba barve las in dlak, izpuščaj na dlaneh in podplatih, izpuščaj, suha koža
Yellow tablets from the last (4th) row of the blister can be disregarded.
Rumene tablete iz zadnje (4.) vrste pretisnega omota se lahko izpusti.
Yellow to beige-coloured, triangular-shaped coated tablet marked “RAPAMUNE 2 mg” on one side.
rumena do bež trikotna obložena tableta, na eni strani označena z “RAPAMUNE 2 mg”.
Yellow to light yellow, capsule shaped tablet, debossed with "93" on one side and “211” on the other.
Rumena do svetlo rumena tableta v obliki kapsule, z vgraviranim napisom “93” na eni strani in “211” na drugi strani tablete.
Yellow, almond-shaped 5 x 8.4 mm film-coated tablets marked with “TL” on one side and “10” on the other side.
Rumena filmsko obložena tableta mandljaste oblike velikosti 5 x 8,4 mm, z vtisnjeno oznako "TL" na eni strani in "10" na drugi strani.
Yellow, capsule-shaped, film-coated tablet debossed with “Teva” on one side and “7541” on the other
Rumene filmsko obložene tablete, v obliki kapsule z oznako "Teva" na eni strani in številko "7541" na drugi strani.
Yellow, convex, ovaloid tablet with a bevelled edge, with “T7” debossed on one side and “NVR” on the other.
Rumena konveksna ovalna tableta z zaobljenim robom, z oznako “T7” vtisnjeno na eni strani in oznako “NVR” na drugi.
Yellow, film-coated capsule shaped tablets.
Rumene, filmsko obložene tablete v obliki kapsule.
Yellow, opaque, hard gelatin capsule, size 3.
rumena, neprozorna, trda želatinska kapsula velikosti 3
Yellow, opaque, oblong (approximately 21 mm) capsule imprinted with “VYN 20” in red.
Rumena, neprozorna, podolgovata (približno 21 mm dolga) kapsula z rdečim napisom “VYN 20”.
Yellow, oval film-coated tablets with dimensions of 11.7 mm x 6.6 mm and debossed with ‘u50’ on one side.
Rumene, ovalne, filmsko obložene tablete z dimenzijami 11,7 mm x 6,6 mm in vtisnjeno oznako u50 na eni strani.
Yellow, oval, approximately 15.6 mm × 7.8 mm, biconvex film-coated tablet debossed with “AV2” on one side and “M” on the other side.
Rumene, ovalne, približno 15,6 x 7,8 mm velike, bikonveksne filmsko obložene tablete z vtisnjeno oznako ''AV2'' na eni strani in ''M'' na drugi strani.
Yellow, oval, biconvex prolonged-release tablets.
Rumene, ovalne in na obeh straneh izbočene tablete s podaljšanim sproščanjem.
Yellow, round and biconvex tablets of 10.1 mm in diameter, engraved with “15” on one side
Rumene, okrogle in bikonveksne tablete premera 10,1 mm, z vrezano oznako “15” na eni strani.
Yellow, round, biconvex tablets approximately 9 mm in diameter debossed with ‘SV 572’ on one side and ‘50’ on the other side.
Rumene, okrogle, bikonveksne tablete premera približno 9 mm, z vtisnjeno oznako ‘SV 572’ na eni in ‘50’ na drugi strani.
Yellow, round-shaped film-coated tablets (10.5 mm diameter) debossed with “DSC L60”.
Rumene, okrogle filmsko obložene tablete, premera 10,5 mm, z vtisnjenim napisom “DSC L60”.
yellow, with number “1”(treatment days 1, 3 and 5; 0.25-ml syringe marking),
rumeno, označeno s številko »1« (za 1., 3. in 5. dan zdravljenja; oznaka 0,25ml na brizgi)
Yellow-coated, capsule-shaped tablet of 17.5 mm length debossed with “100” on one side.
Rumena, obložena tableta v obliki kapsule, dolga 17,5 mm in z vtisnjeno oznako "100" na eni strani.
Yellow-orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1.5 and an “R” on the other side.
Rumeno-oranžne, okrogle, bikonveksne tablete velikosti 6 mm , na eni strani označene z oznako Bayer in na drugi strani z oznakama "1.5" in "R".
yellowing of skin or eyes
porumenelost kože ali očesnih beločnic
yellowing of the skin (jaundice)
porumenelost kože (zlatenica)
yellowing of the skin (jaundice)
rumena koža (zlatenica),
yellowing of the skin (jaundice) liver damage
rumenkasto obarvana koža (zlatenica), poškodba jeter.
yellowing of the skin and eye (jaundice) collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)
porumenelost kože in oči (zlatenica) nabiranje krvi (hematom) v dimljah kot zaplet po posegu na srcu s katetrom, ki je vstavljen v vašo stegensko arterijo (psevdoanevrizma)
yellowing of the skin and eyes (also called jaundice), or other liver disorders;
porumenelost kože in oči (zlatenica) ali druge bolezni jeter;
Yellowing of the skin and eyes (jaundice)
porumenelost kože in oči (zlatenica)
yellowing of the skin and eyes (jaundice)
porumenitev kože in oči (zlatenica)
yellowing of the skin and the eyes (jaundice)
porumenelost kože in oči (zlatenica)
yellowing of the skin and white part of eyes,
porumenelost kože in očesnih beločnic,
Yellowing of the skin and whites of the eyes
porumenela koža in beločnice (zlatenica)
yellowing of the skin and whites of the eyes (jaundice), or an increase in liver enzymes - these may be signs of an inflamed liver (hepatitis and hepatic failure) increased sensitivity of your skin to sunlight, sun lamps and sunbeds
rumeno obarvanje kože in beločnic (zlatenica) ali zvišane ravni jetrnih encimov - to so lahko znaki vnetja jeter (hepatitisa ali jetrne odpovedi), povečana občutljivost vaše kože za sončno svetlobo ter za svetilke in naprave za sončenje.
yellowing of the skin and whites of the eyes (jaundice), or an increase in liver enzymes - these may be signs of an inflamed liver (hepatitis and hepatic failure). increased sensitivity of your skin to sunlight, sun lamps and sunbeds
rumeno obarvanje kože in beločnic (zlatenica) ali zvišane ravni jetrnih encimov - to so lahko znaki vnetja jeter (hepatitisa ali jetrne odpovedi), povečana občutljivost vaše kože za sončno svetlobo ter za svetilke in naprave za sončenje.
yellowing of the skin and/or eyes (jaundice)
porumenelost kože in oči (zlatenica),
Yellowing of the skin and/or eyes (jaundice)
rumeno obarvanje kože in/ali očesnih beločnic (zlatenica)
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Če ste vzeli ali je otrok vzel prevelik odmerek zdravila REYATAZ, se lahko pojavi rumeno obarvanje kože in/ali očesnih beločnic (zlatenica) in nepravilen srčni utrip (podaljšanje intervala QTc).
yellowing of the skin and/or eyes (jaundice) blistering rash
porumenelosti kože in/ali oči (zlatenici), mehurčastem izpuščaju.
yellowing of the skin and/or eyes (jaundice) blistering rash.
porumenelosti kože in/ali oči (zlatenici), mehurčastem izpuščaju.
yellowing of the skin and/or eyes increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium change in the way the heart beats
rumeno obarvanje kože in/ali oči povečana občutljivost kože za sonce, tudi če gre za indirektno izpostavljenost soncu (čez oblake, meglo) in UV (ultravijolično) svetlobo, na primer UV svetlobo v solariju. sprememba v načinu bitja srca
yellowing of the skin and/or eyes, increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium, change in the way the heart beats.
rumeno obarvanje kože in/ali oči, povečana občutljivost kože za sonce, tudi če gre za indirektno izpostavljenost soncu (čez oblake, meglo) in UV (ultravijolično) svetlobo, na primer UV svetlobo v solariju, sprememba v načinu bitja srca.
Yellowing of the skin or the white part of the eyes
porumenelost kože ali očesne beločnice,
yellowing of the skin or the whites of the eyes (jaundice) unusually dark-coloured urine
rumeno obarvanje kože ali očesnih beločnic (zlatenica), neobičajno temno obarvan urin,
yellowing of the skin or whites of the eyes (jaundice)
rumeno obarvanje kože ali očesnih beločnic (zlatenica),
yellowing of the skin or whites of the eyes unusually dark urine or pale stools
porumenelost kože ali beločnic, nenavadno temen urin ali bledo blato.
Yellowing of your skin and eyes (jaundice), abdominal pain or swelling, nausea or vomiting, which could be symptoms of liver problems including liver failure
Porumenelost kože in očesnih beločnic (zlatenica), bolečine v trebuhu ali oteklost trebuha, slabost v želodcu ali bruhanje, ki so lahko simptomi težav z jetri, vključno z odpovedjo jeter.
Yellowing of your skin or the white part of your eyes
porumenitev kože ali očesnih beločnic;
Yellowing of your skin or the white part of your eyes caused by high levels of bilirrubin in your blood has been commonly reported.
Pogosto so poročali o rumenem obarvanju kože ali očesnih beločnic, ki je posledica visokih vrednosti bilirubina v krvi.
Yellowing of your skin or the whites of your eyes
porumenelost kože ali beločnic,
yellowing of your skin or the whites of your eyes (jaundice)
porumenelost kože ali beločnic (zlatenica),
Yellowing of your skin or the whites of your eyes (jaundice)
porumenelost kože ali beločnice (zlatenica),
yellowing of your skin or the whites of your eyes (jaundice)
rumeno obarvanje kože in očesnih beločnic (zlatenico),